Top of this page
Skip navigation, go straight to the content

Investors UCB Governance

UCB Governance

?The Company is administered by a Board of Directors and run by an Executive Committee, whose respective functions and responsibilities are clearly defined in the?Corporate Governance Charter.

The General Meeting of Shareholders is convened once a year, on the last Thursday of April, for its Ordinary meeting. A General Meeting of Shareholders may also be called in Special or Extraordinary circumstances whenever the Company interests dictate. Rules relating to General Meetings and main rights and obligations of Shareholders are further detailed in the Corporate Governance Charter.

?

Board of Directors

?

UCB Board and Committees

To enhance the overall effectiveness of the Board by ensuring focus, oversight and monitoring of sensitive areas, the Board has created three specialist committees:

Board of Directors

  • 13 members
  • 7 independent directors (54%)
  • 5 nationalities
  • 5 women (38%)
  • 4-year mandate
  • age limit: 70

?

Executive Committee

  • 13 members
  • 6 nationalities
  • 3 women (23%)

?

Members of Board of Directors

Evelyn du Monceau

Chair of the Board

Gerhard Mayr

First appointed in 1984

End of term in 2023

Chair of the GNCC

Pierre Gurdjian

Vice Chairman & Independent?Director

image description

First appointed in 2016

End of term in 2020

Member of the GNCC

Jean-Christophe Tellier

Executive Director

image description

First appointed in 2014

End of term in 2022

?

Jan Berger

Independent?Director

image description

First appointed in 2019

End of term in 2023

?

Alice Dautry

Independent?Director

image description

First appointed in 2015

End of term in 2023

Member of the Scientific Committee

Kay Davies

Independent?Director

image description

First appointed in 2014

End of term in 2022

Chair of the Scientific Committee

Member of the GNCC

Albrecht De Graeve

Independent?Director

image description

First appointed in 2010

End of term in 2021

Chairman of the Audit Committee

Roch Doliveux

Director

image description

Appointed in 2017

End of term in 2021

?

Charles-Antoine Janssen

Director

image description

First appointed in 2012

End of term in 2020

Member of the Audit Committee

Cyril Janssen

Director

image description

First appointed in 2015

End of term in 2023

Viviane Monges

Independent?Director

image description

First appointed in 2017

End of term in 2021

Member of the Audit Committee

Cédric van Rijckevorsel

Director

image description

First appointed in 2014

End of term in 2022

Ulf Wiinberg

Independent Director

image description

First appointed in 2016

End of term in 2020

Member of the Audit Committee

?

Members of the Executive Committee

We have adapted the organization structure on four pillars around which we are creating value for each patient, centered by our focus and integrated across functional teams around different patient populations.

Jean-Christophe Tellier

Jean-Christophe Tellier

Chief Executive Officer and
Chairman of the Executive Committee

Joined UCB in 2011
Appointed as CEO in 2015

?

Iris L?w-Friedrich

Pascale Richetta

Executive Vice President
Chief Medical Officer

Joined UCB in 2006
Appointed in 2008

Emmanuel Caeymaex

Emmanuel Cayemaex

Executive Vice President
Head of Immunology Solutions

Joined UCB in 1994
Appointed in 2015

?

Kirsten Lund-Jurgensen

image description

Executive Vice President
Head of Supply & Technology Unit

Joined UCB in 2019
Appointed in 2019

Jean Luc Fleurial

Iris Loew-Friedrich

Executive Vice President?
Chief Talent Officer

Joined UCB in 2017
Appointed in 2017

?

Alexander Moscho

image description

Executive Vice President
Chief Strategy Officer

Joined UCB in 2017
Appointed in 2017

Dhaval Patel?

image description

Executive Vice President
Chief Scientific Officer

Joined UCB in 2017
Appointed in 2017

Pascale Richetta

Pascale Richetta

Executive Vice President
Bone Patient Value Unit Head

Joined UCB in 2016
Appointed in 2016

Bill Silbey

Pascale Richetta

Executive Vice President
Patient Value Legal Function and General Counsel

Joined UCB in 2011
Appointed in March 2019

Bharat Tewarie

Bharat Tewarie

Executive Vice President
Chief Marketing Officer

Joined UCB in 2015
Appointed in 2015

Detlef Thielgen

image description

Executive Vice President
Chief Financial Officer

Joined UCB in 2006
Appointed in 2007

Charl van Zyl

image description

Executive Vice President
Head of Neurology Solutions

Joined UCB in 2017
Appointed in 2017

Jeff Wren

image description

Executive Vice President

Joined UCB in 2010
Appointed in 2015

Leaving on 31 October 2019 and handing over to Charl van Zyl

Shareholders and shareholders meetings

Find out about UCB shareholders, their transparency notifications and our shareholders meetings on the dedicated webpage.

Main corporate governance documents

UCB has adopted the Belgian Code of Corporate Governance (second edition) published on March 2009 as its reference Code taking into account the specific international aspects of the Company. As part of these rules, UCB, as a publicly traded company, has adopted a Code of Business Conduct, including a Code of Share Dealing.

The Corporate Governance Charter established by the Board of Directors aims at providing a comprehensive and transparent disclosure of the Company’s governance. It defines the system of checks and balances between the shareholders/investors, the Board and the management to shape an efficiently functioning company, ideally geared to produce long-term, sustainable value. It will be continuously updated as required.

Articles of Association

Special reports of the Board

爱导航